2-methoxyestradiol inhibits longitudinal bone growth in normal female rats

Calcified Tissue International

Volumn 66, Issue 6, 2000, Pages 465-469

  Turner, R T ^a   Evans, G L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bone formation; Bone histomorphometry; Bone resorption; Estrogen metabolites; Growth plate

Indexed keywords

2 METHOXYESTRADIOL; CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; BONE GROWTH; BONE TURNOVER; CANCELLOUS BONE; CARTILAGE CELL; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; GROWTH PLATE; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIA; UTERUS WEIGHT;

ANIMALS; BONE AND BONES; CHOLESTEROL; ESTRADIOL; FEMALE; ORGAN SIZE; OSTEOGENESIS; RATS; RATS, INBRED F344; TIBIA; UTERUS;

EID: 0034084027     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230010093     Document Type: Article

References (35)

1. King RJB (1961) Metabolism of oestradiol in vivo. Biochem J 79:361-369
2. Hoffman AR, Paul SM, Axelrod J (1980) Estrogen-2-hydroxylase in the rat: distribution and response to hormonal manipulation. Biochem Pharmacol 29:83-87
3. Barbieri RL, Canick JA, Ryan KF (1978) Estrogen-2-hydroxylase activity in rat. Tissues Steroids 32:529-538
4. Ball P, Knupper R, Haupt M, Breuer H (1972) Interactions between estrogens and catecholamines III. Studies on the methylation of catecholestrogens, catechol amines and other catechols by the catechol-O-methyltransferase of human liver. J Clin Endocrinol Metab 34:736-746
5. Merriam GR, MacLusky NJ, Picard MK, Naftolin F (1980) Comparative properties of the catechol estrogen: 1 Methylation by catechol-o-methyltransferase and binding to cytosol, estrogen receptors. Steroids 36:1-11
6. Fotsis T, Zhang Y, Pepper S, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L ( 1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368:237-239
7. Tsukamoto A, Kaneko Y, Yoshida T, Han K, Ichinose M, Kimura S ( 1998) 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and β-galactosidase expression in vascular endothelial cells. Biochem Biophys Res Comm 248:9-12
8. Mukhopadhyay T, Roth JA (1998) Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene 17:241-246
9. Nishigaki I, Sasaguri Y, Yagi K (1995) Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta atherosclerosis. Atherosclerosis 113:167-170
10. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81-86
11. Seegers JC, Lottering ML, Grobler CJS, van Papendorp DH, Habbersett RC, Shou Y, Lehnert BE (1997) The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J Steroid Biochem Mol Biol 62:253-267
12. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E (1994) 2-Methyoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968
13. Attalla H, Makela TP, Adlercreutz H, Andersson LC (1996) 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem Biophys Res Comm 228:467-473
14. Zhu BT, Conney AH (1998) Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 58:2269-2277
15. McLean FC, Urist MR (1961) In: DeBruyn PP (ed) Bone. University of Chicago Press, Chicago, pp 22-25
16. Turner RT, Evans GL, Sluka JP, Adrian MD, Bryant HU, Turner CH, Sato M (1998) Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene. Endocrinology 139:3712-3720
17. Dobnig H, Turner RT (1995) Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638
18. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS (1983) Relationships between surface, volume and thickness of iliac trabecular bone in aging and osteoporosis: implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409
19. Turner RT, Evans GL, Wakley GK (1994) Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134: 461-466
20. Turner RT, Vandersteenhoven JJ, Bell NH (1987) The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115-122
21. Liu D, Bachmann KA (1998) An investigation of the relationship between estrogen, estrogen metabolites, and blood cholesterol levels in ovariectomized rats. J Pharmacol Exp Ther 286:561-568
22. Lundeen SG, Carver JM, McKean M-L, Winneker RC (1997) Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology 138:1552-1558
23. Cypriani B, Tabacik C, Descomps B, Crastes de paulet A (1988) Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis. J Steroid Biochem 31:763-77
24. Kauffman RF, Bryant HU (1995) Selective estrogen receptor modulators. Drug News Perspect 8:531-539
25. Sibonga JD, Dobnig H, Harden RM, Turner RT (1998) Effect of the high-affinity estrogen receptor ligand ICI 182, 780 on the rat tibia. Endocrinology 139:3736-3742
26. Wronski TJ, Schenck PA. Cintron M, Walsh CC (1987) Effect of body weight on osteopenia in ovarectomized rats. Calcif Tissue Int 40:155-159
27. Westerlind KC, Sarkar G. Bolander ME, Turner RT (1995) Estrogen receptor mRNA is expressed in vivo in rat calvarial periosteum. Steroids 60:484-487
28. Turner RT, Spector M, Bell NH (1991) Ethanol-induced abnormalities in bone formation, turnover, mechanical properties and mineralization in young adult rats. Cells Mater (suppl) 1:167-173
29. Grohe C, Kahlert S, Lobbert K, Meyer R, Linz KW, Karas RH, Vetter H (1996) Modulation of hypertensive heart disease by estrogen. Steroids 61:201-204
30. Dubey RK, Gillespie DG, Jackson EK, Keller PJ (1998) 17β-estradiol, its metabolites, and progesterone inhibit fibroblast growth. Hypertension 31:522-528
31. Josefsson E, Tarkowski A (1997) Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum 40:154-163
32. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 331:1056-1061
33. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698
34. Westerlind KC, Gibson KJ, Malone P, Evans GL, Turner RT (1998) Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J Bone Miner Res 13:1023-1031
35. Du Caju MV, Bleyaert S, Op De Beeck L (1993) Growth inhibition using estrogens in constitutionally tall girls. Acta Clin Belg 48:11-19